New search    Hide text from Guidelines

This group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.

Estrogens and progestogens used specifically in the treatment of neoplastic diseases are classified in this group. This means that some strengths may be classified in this group, while remaining strengths are classified in G03 - Sex hormones and modulators of the genital system.

Antigrowth hormones like somatostatin and octreotide, which are also used in the treatment of neoplastic diseases, are classified in H01CB.

Polyestradiol and combined products, which contain polyestradiol and local anestethics, are classified at the plain level L02AA02 - polyestradiol phosphate.

ATC code	Name	DDD	U	Adm.R	Note
L02AA04	fosfestrol	0.25	g	O
		0.25	g	P

List of abbreviations